Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Citius Pharmaceuticals, Inc. | f10q1217_citiuspharma.htm |
| EX-31.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10q1217ex31-2_citius.htm |
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10q1217ex31-1_citius.htm |
| EX-10.2 - CITIUS PHARMACEUTICALS, INC. 2018 OMNIBUS STOCK INCENTIVE PLAN - Citius Pharmaceuticals, Inc. | f10q1217ex10-2_citius.htm |
| EX-10.1 - RELEASE AGREEMENT, DATED NOVEMBER 7, 2017, BETWEEN CITIUS PHARMACEUTICALS, INC., - Citius Pharmaceuticals, Inc. | f10q1217ex10-1_citius.htm |
EXHIBIT 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AND THE CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Citius Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Myron Holubiak, Chief Executive Officer of the Company and Jaime Bartushak, Chief Financial Officer, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: February 14, 2018 | By: | /s/ Myron Holubiak |
| Myron Holubiak | ||
| Chief Executive Officer, | ||
| (Principal Executive Officer) | ||
| Date: February 14, 2018 | By: | /s/ Jaime Bartushak |
| Jaime Bartushak | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) |